Steffen Thirstrup’s Post

View profile for Steffen Thirstrup, graphic

Chief Medical Officer at European Medicines Agency

20 year's experience has generated strong scientific support for interchangeability of biosimilars approved according to standards set by major regulatory authorities such as #FDA and #ema. This statement from US-FDA is fully aligned with our statement from April 2023 (https://lnkd.in/d9Fkqmk5) underpinning that biosimilars offers an alternative that are equally safe and effective as their reference counterparts

View organization page for FDA, graphic

775,411 followers

CDER’s recent research takes the Spotlight! 🌟 Check out the latest Spotlight on CDER Science, which highlights research that examined the safety aspects of switching between reference #biologics and #biosimilars: https://lnkd.in/d2s2EtHU

  • Image of tablet screen showing "Safety Outcomes When 'Switching' Between Biosimilars and Reference Products" webpage.

To view or add a comment, sign in

Explore topics